Physician profile
Tyler Harvey
NPI 1932547239
$4,144.79
in general payments reported to CMS, 2019-2025
24 companies · $2,965 in 2025
The $2,965 reported for 2025 was more than what 95% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $322 · 2020: $122 · 2021: $34.98 · 2022: $259 · 2023: $235 · 2024: $206 · 2025: $2,965.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $1,500 · Travel and Lodging: $1,079 · Food and Beverage: $827.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $1,500.00 |
| Travel and Lodging | $1,079.29 |
| Food and Beverage | $826.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,596.28 | 2025 | |
| Sumitomo Pharma America, INC. | $229.94 | 2023-2025 | Myfembree, Gemtesa |
| Abbvie INC. | $228.03 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $183.79 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $120.88 | 2019-2025 | |
| Boston Scientific Corporation | $97.34 | 2025 | General - Female Sui |
| Daiichi Sankyo INC. | $95.41 | 2019-2023 | Injectafer |
| Astellas Pharma US INC | $89.55 | 2025 | Veozah |
| Exeltis, USA INC. | $81.40 | 2022-2025 | Slynd |
| Organon LLC | $62.49 | 2024-2025 | Jada System |
| Aspira Women'S Health INC | $58.78 | 2022 | |
| Therapeuticsmd, INC. | $54.08 | 2019-2020 | |
| Axonics, INC. | $29.42 | 2024 | Axonics |
| Myovant Sciences INC. | $29.19 | 2022 | |
| Avion Pharmaceuticals | $28.12 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $26.12 | 2019 | |
| Merck Sharp & Dohme LLC | $24.03 | 2019-2020 | |
| Urovant Sciences INC | $21.33 | 2022 | |
| Roche Diagnostics Corporation | $19.92 | 2019 | |
| Pfizer INC. | $15.43 | 2025 | |
| Dexcom, INC. | $14.38 | 2024 | Dexcom G6 Transmitter |
| Amgen INC. | $13.77 | 2019 | |
| Teleflex LLC | $13.46 | 2019 | |
| Lupin INC. | $11.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tyler Harvey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.